Literature DB >> 27314501

Rapid activity prediction of HIV-1 integrase inhibitors: harnessing docking energetic components for empirical scoring by chemometric and artificial neural network approaches.

Patcharapong Thangsunan1,2, Sila Kittiwachana3, Puttinan Meepowpan3, Nawee Kungwan3, Panchika Prangkio2, Supa Hannongbua4, Nuttee Suree5.   

Abstract

Improving performance of scoring functions for drug docking simulations is a challenging task in the modern discovery pipeline. Among various ways to enhance the efficiency of scoring function, tuning of energetic component approach is an attractive option that provides better predictions. Herein we present the first development of rapid and simple tuning models for predicting and scoring inhibitory activity of investigated ligands docked into catalytic core domain structures of HIV-1 integrase (IN) enzyme. We developed the models using all energetic terms obtained from flexible ligand-rigid receptor dockings by AutoDock4, followed by a data analysis using either partial least squares (PLS) or self-organizing maps (SOMs). The models were established using 66 and 64 ligands of mercaptobenzenesulfonamides for the PLS-based and the SOMs-based inhibitory activity predictions, respectively. The models were then evaluated for their predictability quality using closely related test compounds, as well as five different unrelated inhibitor test sets. Weighting constants for each energy term were also optimized, thus customizing the scoring function for this specific target protein. Root-mean-square error (RMSE) values between the predicted and the experimental inhibitory activities were determined to be <1 (i.e. within a magnitude of a single log scale of actual IC50 values). Hence, we propose that, as a pre-functional assay screening step, AutoDock4 docking in combination with these subsequent rapid weighted energy tuning methods via PLS and SOMs analyses is a viable approach to predict the potential inhibitory activity and to discriminate among small drug-like molecules to target a specific protein of interest.

Entities:  

Keywords:  AutoDock4; HIV-1 integrase; Molecular docking; PLS; SOMs; Scoring

Mesh:

Substances:

Year:  2016        PMID: 27314501     DOI: 10.1007/s10822-016-9917-0

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  52 in total

1.  Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins.

Authors:  P S Charifson; J J Corkery; M A Murcko; W P Walters
Journal:  J Med Chem       Date:  1999-12-16       Impact factor: 7.446

Review 2.  Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry.

Authors:  F Ooms
Journal:  Curr Med Chem       Date:  2000-02       Impact factor: 4.530

3.  Assessing scoring functions for protein-ligand interactions.

Authors:  Philippe Ferrara; Holger Gohlke; Daniel J Price; Gerhard Klebe; Charles L Brooks
Journal:  J Med Chem       Date:  2004-06-03       Impact factor: 7.446

4.  Supervised self-organizing maps in drug discovery. 2. Improvements in descriptor selection and model validation.

Authors:  Yun-De Xiao; Rebecca Harris; Ersin Bayram; Peter Santago Ii; Jeffrey D Schmitt
Journal:  J Chem Inf Model       Date:  2006 Jan-Feb       Impact factor: 4.956

Review 5.  Docking and scoring--theoretically easy, practically impossible?

Authors:  B Coupez; R A Lewis
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

Review 6.  Diketo acids derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.

Authors:  R Di Santo
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

7.  Investigation of novel chemical inhibitors of human lysosomal acid lipase: virtual screening and molecular docking studies.

Authors:  Syed Sikander Azam; Sumra Wajid Abbasi; Shifa Tahir
Journal:  Comb Chem High Throughput Screen       Date:  2014       Impact factor: 1.339

8.  High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors.

Authors:  Venkataswamy Sorna; Emily R Theisen; Bret Stephens; Steven L Warner; David J Bearss; Hariprasad Vankayalapati; Sunil Sharma
Journal:  J Med Chem       Date:  2013-11-23       Impact factor: 7.446

9.  Structural-Functional Analysis of 2,1,3-Benzoxadiazoles and Their N-oxides As HIV-1 Integrase Inhibitors.

Authors:  S P Korolev; O V Kondrashina; D S Druzhilovsky; A M Starosotnikov; M D Dutov; M A Bastrakov; I L Dalinger; D A Filimonov; S A Shevelev; V V Poroikov; Y Y Agapkina; M B Gottikh
Journal:  Acta Naturae       Date:  2013-01       Impact factor: 1.845

10.  Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.

Authors:  Lewis R Vidler; Panagis Filippakopoulos; Oleg Fedorov; Sarah Picaud; Sarah Martin; Michael Tomsett; Hannah Woodward; Nathan Brown; Stefan Knapp; Swen Hoelder
Journal:  J Med Chem       Date:  2013-10-03       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.